Strive to be the host of the morning meeting
Release time:
2020-08-14
Striving to be the host of the morning meeting
The morning meeting is a major feature of the cable company, which has persisted for nearly ten years unconsciously. Wang Debo, the production director, is the host of our morning meeting. He goes through the same set of procedures step by step every day. He can work well without thinking. Looking at the almost numb expression of the employees under the stage, Wang Debo was anxious. How can the morning meeting really play its role?
Looking back on TV programs such as "I am a singer" and "Happy Comedian", Wang Debo suddenly had a big brain opening. With so many excellent employees in the company, why not let them show their elegant demeanour? Although the employees take turns to take the stage every day to be inspired, the host has never been a host. The host of
is not so good either. The host is the key to whether the morning meeting is good or not. He needs to have charisma and adaptability.
The first to bear the brunt was Yang Huawei, the leader of the packaging class. His high-pitched voice was inspiring. He organized the team in an orderly manner, and we were like soldiers on the battlefield, holding our heads high, imposing, and full of positive energy to start our new day.
"A beautiful day starts with the morning meeting". Li Yuegen, who has a star model, opened the morning meeting in such opening remarks. His body language is rich, the host is full of voice and emotion, and he will improvise a few words from time to time to bring us freshness. Cai shunrong, monitor of
city cable, is shy in his hosting style. Don't look at him when he works in a flurry of fire, as soon as he takes the stage, he is like a different person. He immediately becomes docile and gives people a refreshing feeling. Although Li Jianxin, the monitor of
electric cable, was not good at words, he still plucked up the courage to set an example for the team. He completed his first show in an unhurried, orderly and easy way. He was like a veteran and was well received by everyone.
...
Corporate culture is people-oriented and respects people's emotions, so as to create a harmonious atmosphere of unity, friendship and mutual trust in the enterprise, strengthen the sense of group, and form a strong cohesion and centripetal force among the employees of the enterprise. Every morning we gather together to muster up morale and work hard for a common goal. As long as we are willing, the stage of the morning meeting is yours! (Qian Fang)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page